Akebia Therapeutics Inc

General ticker "AKBA" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $409.7M

Akebia Therapeutics Inc follows the US Stock Market performance with the rate: 27.2%.

Estimated limits based on current volatility of 2.1%: low 1.80$, high 1.87$

Factors to consider:

  • Company does not operate outside North America (retrieved using AI)
  • Price in estimated range
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [0.96$, 2.07$]
  • 2024-12-30 to 2025-12-30 estimated range: [0.86$, 1.91$]

Financial Metrics affecting the AKBA estimates:

  • Negative: Non-GAAP EPS, $ of -0.28 <= 0.10
  • Negative: Operating profit margin, % of -19.20 <= 1.03
  • Negative: Operating cash flow per share per price, % of -10.03 <= 2.35
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Negative: Inventory ratio change, % of 1.66 > 1.08
  • Negative: Industry earnings per price (median), % of -26.04 <= 1.31

Similar symbols

Short-term AKBA quotes

Long-term AKBA plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $211.65MM $292.48MM $194.62MM
Operating Expenses $476.15MM $373.26MM $240.88MM
Operating Income $-264.50MM $-80.78MM $-46.26MM
Non-Operating Income $-17.52MM $-13.45MM $-5.67MM
Interest Expense $19.94MM $15.69MM $6.03MM
R&D Expense $147.85MM $129.11MM $63.08MM
Income(Loss) $-282.02MM $-94.23MM $-51.92MM
Profit(Loss) $-282.02MM $-94.23MM $-51.92MM
Stockholders Equity $74.01MM $5.23MM $-30.58MM
Inventory $38.20MM $21.76MM $15.69MM
Assets $529.35MM $356.05MM $241.70MM
Operating Cash Flow $-252.97MM $-73.15MM $-23.38MM
Capital expenditure $0.06MM $0.11MM $0.00MM
Investing Cash Flow $39.94MM $-0.11MM $0.00MM
Financing Cash Flow $133.73MM $14.60MM $-25.21MM
Earnings Per Share* $-1.48 $-0.58 $-0.28

* EPS are Split Adjusted, recent splits may be reflected with a delay.